Meatable
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
Meatable B.V. was a Dutch cultivated-meat startup founded in 2018, developing lab-grown pork (later also beef, lamb and chicken) using patented Opti-Ox technology. The company raised more than $100 million in venture funding from investors including Agronomics, and in 2025 acquired the cultivated-meat platform of UK biotech Uncommon Bio to broaden its technology. Throughout 2025 it was hit by funding difficulties, and on December 19, 2025 the board and shareholders resolved to dissolve the company and terminate all operating activities in an orderly wind-down under statutory liquidation procedures.
02 / Meatable FAILURE REASONS
Failure reasons
Meatable collapsed when venture capital turned cold on cultivated meat. The company had raised more than $100 million, but the sector's long path to commercial viability - a decade or more - collided with venture timelines that demand big returns in five to seven years. Throughout 2025, foreseeable and unforeseeable risks hit its ability to execute, and it could not secure continued funding from existing shareholders or new investors. After a review of strategic options, the board and shareholders chose an orderly wind-down over a distressed sale, and investor Agronomics wrote its £7.9 million investment down to zero.
03 / EVENT HISTORY
Events in the structured record
- Liquidation
Meatable terminated operations and entered liquidation in December 2025 after it could not secure sufficient funding from existing or new investors.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
Founded 2018 in the Netherlands; cultivated pork (later multi-protein) via patented Opti-Ox technology.
- 02
Raised more than $100 million in venture funding; investors included Agronomics.
- 03
2025: acquired the cultivated-meat platform of UK biotech Uncommon Bio.
- 04
Unable to secure continued funding from existing or new investors throughout 2025.
- 05
Dec 19, 2025: board and shareholders resolved to dissolve the legal entity and terminate all operating activities; orderly wind-down under statutory liquidation.
- 06
Agronomics wrote its £7.9 million investment down to zero (carried value £11.9 million).
- 07
No reliable disclosed loss figure for Meatable itself; investor write-offs are not company losses.